|Adult ADHD Home||Succeed at Work||ADHD Self Test|
|Love & Friendships||Manage Time & Money||ADHD Adult Blogs|
|The Organized Life||Stress, Sleep, Health||Adult Support Groups|
|Apps & Gadgets||Inspirational Stories||Expert Answers|
|ADHD Parenting Home||Schedules & Time||Sample Routines|
|Discipline & Behavior||Teens & Young Adults||Parent Support Group|
|ADHD Parenting Skills||Nutrition & Diet||Parenting Blogs|
|Friendships & Social Skills||Sports & Hobbies||Summer & Camps|
|ADHD Treatment Home||ADHD Medications||Medication Reviews||Adderall|
|Treating Your Child||Nutrition & Diet||Fish Oil Printable||Daytrana|
|Expert Q&As||Non-Medical Treatment||Find Professionals||Strattera|
|Behavior Therapy||Brain Training||Quillivant XR||Vyvanse|
|ADHD/LD School Home||High School & College||Accommodations|
|IEPs & 504s||ADHD Study Skills||ADHD School Guide|
|Working with School||School Organization Help||College Survival Guide|
|Social Skills at School||For Teachers Only||Is it LD? A Self Test|
|ADHD Diagnosis Home||ADHD & Women||Is it ADHD? Self Tests|
|Getting a Diagnosis||Is it a Related Condition?||Medical Q&As|
|ADHD Symptoms||Post Diagnosis Next Steps||Myths & Realities|
|Is it Learning Disabilities?||ADHD Treatment||ADHD Support Groups|
|Tools and Checklists|
|ADHD Topics A-Z|
|Share Your Story|
|Give a Gift|
|Buy Back Issues|
Canadian Market Suspends Sales of Adderall XR
The FDA has no plans to remove the drug that's been linked to 20 reports of sudden death in Canada.
Wednesday February 16th - 12:00am
On February 9, 2005, Canadian regulators suspended all sales of the long-acting stimulant medication Adderall XR. The decision was based on safety information released by the manufacturer, specifically, 20 reports of sudden deaths linked to the medication over the course of four years.
Currently, the FDA has no plans to remove the drug from the U.S. market, citing pre-existing conditions in some of the patients as well as the relative rarity of the deaths when compared to the 30 million prescriptions written within that time period. The FDA is deciding whether to conduct its own study of the drug, and will continue to closely monitor safety reports.
Stay turned for an in-depth look at the Adderall XR story in the next issue of ADDitude magazine.
<table align="center" cellpadding="10">